Arrivent Biopharma Inc (AVBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
06-2024 | 03-2024 | 12-2023 | 06-2023 | 03-2023 | |
Operating Expenses | 25,697 | 20,674 | 0 | 22,584 | 12,172 |
Operating Income | -25,697 | -20,674 | N/A | -22,584 | -12,172 |
Other Income | 3,823 | 3,257 | 0 | 1,017 | 0 |
Pre-tax Income | -21,874 | -17,417 | 0 | -21,567 | -12,172 |
Net Income Continuous | -21,874 | -17,417 | N/A | -21,567 | -12,172 |
Net Income | $-21,874 | $-17,417 | $N/A | $-21,567 | $-12,172 |
EPS Basic Total Ops | -0.65 | -0.70 | N/A | -10.79 | -9.45 |
EPS Basic Continuous Ops | -0.65 | -0.70 | N/A | -19.61 | -9.45 |
EPS Diluted Total Ops | -0.65 | -0.70 | N/A | -10.79 | -9.45 |
EPS Diluted Continuous Ops | -0.65 | -0.70 | N/A | -19.61 | -9.45 |
EPS Diluted Before Non-Recurring Items | -0.65 | -0.70 | N/A | N/A | N/A |
EBITDA(a) | $-25,697 | $-20,674 | $N/A | $-22,584 | $-12,172 |